Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Grifols Sees Annual Savings of $230 Million After 2015

Don't Miss Out —
Follow us on:

(Corrects currency of capital expenditure to dollars after Grifols corrected regulatory filing.)

Oct. 17 (Bloomberg) -- Grifols SA expects to generate annual synergies of $230 million beyond 2015 after its merger with Talecris Biotherapeutics Holdings Corp, the company said in

a presentation filed to regulators today.

Grifols, which holds an investor’s day in Barcelona Oct. 17

and Oct. 18, said total capital expenditure from 2011 to 2015 will be $964 million, while integration costs will be $70 million to 2014, lower than the initial estimate, the company said.

Link to Company News:{GRF SM <Equity> CN <GO>}

To contact the editor responsible for this story: Emma Ross-Thomas at erossthomas@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.